Thomas W. Beetham, Chief Operating Officer at Viridian Therapeutics, Inc.\DE (VRDN), bought 5,000 shares at $23.41 ($117K) on 2024-09-27, disclosed to the SEC on 2024-09-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| KNSA | SELL | 2020-07-02 | $1.5M | — | Filing → |
| KNSA | SELL | 2020-06-12 | $690K | — | Filing → |
| KNSA | SELL | 2020-04-22 | $1.9M | — | Filing → |